The graphic shows how damage to the cristae affects cell metabolism and the extracellular environment, and can thereby contribute to the development of mitochondrial liver disease.
Image Credit: © HU/Ruchika Anand/AI-generated
Scientific Frontline: Extended "At a Glance" Summary: MIC13-Linked Mitochondrial Liver Disease
The Core Concept: Mitochondriopathies are severe cellular disorders caused by damaged mitochondria, the energy-producing centers of the cell. A specific variant of the MIC13 protein disrupts the mitochondria's internal structure, driving early-stage liver disease.
Key Distinction/Mechanism: Unlike the previous assumption that cellular environmental changes are merely a consequence of advanced liver damage, a disease-causing MIC13 variant directly disrupts the inner mitochondrial membrane folds (cristae). This structural failure immediately alters amino-acid, lipid, and energy metabolism, which in turn triggers increased collagen accumulation and early fibrotic remodeling in the extracellular matrix.
Major Frameworks/Components:
- Mitochondrial Cristae Architecture: The structural folds of the inner mitochondrial membrane, organized by the MIC13 protein, which are critical for proper cellular metabolic function.
- Extracellular Matrix (ECM) Remodeling: The structural support network surrounding cells that undergoes early fibrotic changes, such as abnormal collagen accumulation, due to mitochondrial dysfunction.
- Pluripotent Stem Cell Modeling: Advanced cell models genetically modified to generate liver cells that accurately display key features of mitochondrial disease, bypassing previous research limitations.
Branch of Science: Biochemistry, Molecular Biology, Hepatology, and Cellular Biology.
Future Application: The pluripotent stem cell models developed for this research provide a new platform for screening metabolic or molecular vulnerabilities, enabling the development of targeted therapeutic strategies for mitochondrial liver disorders.
Why It Matters: This research demonstrates that mitochondrial dysfunction actively and directly influences the extracellular environment of liver cells in the early stages of disease, shifting the focus of future treatments toward early fibrotic intervention and metabolic correction.
As the “powerhouse of the cells,” mitochondria supply cells with energy. They also play an important role in metabolism. The Institute of Biochemistry and Molecular Biology I at Heinrich Heine University Düsseldorf (HHU) and University Hospital Düsseldorf (UKD) are researching the role of mitochondria in the development of certain diseases. In a recent study, researchers from the institute show how damaged mitochondria may contribute to liver disease. The researchers, led by Principal Investigator Dr. Ruchika Anand, have now published their findings in the scientific journal Cell Death & Disease.
Disorders attributable to damaged mitochondria are referred to as mitochondriopathies. These also include severe mitochondrial liver disease, whereby the liver can be affected in around 20% of mitochondriopathies. The research focuses on the exact processes in the cell that contribute to the development of mitochondriopathies. The researchers, led by Principal Investigator Dr. Ruchika Anand, have now identified a mechanism in the mitochondria that could contribute to the development of mitochondrial liver disease.
They studied MIC13, a protein that helps organize the inner mitochondrial membrane and its characteristic folds, known as cristae. They investigated a disease-causing MIC13 variant associated with early-onset mitochondrial hepatoencephalopathy, a severe mitochondrial liver disorder. Cell models derived from pluripotent stem cells were used as the basis for the study. The researchers succeeded in genetically modifying these cells so that they generated liver cells displaying key features of the mitochondrial disease. The development of these models expands the previously limited options for researching this mitochondriopathy.
The researchers demonstrated that the disruption of mitochondrial cristae was accompanied by extensive changes in cellular metabolism, including alterations in amino acid, lipid, and energy metabolism. These metabolic changes were also associated with changes in the extracellular matrix, including increased collagen accumulation and altered cell migration. The extracellular matrix provides structural support around cells and helps regulate how they communicate, move, and respond to their environment. Changes in the extracellular matrix are an important feature of tissue remodeling. The findings thus suggest that mitochondrial dysfunction may influence the extracellular environment of liver cells at an early stage of disease, rather than these changes being simply a consequence of advanced liver damage.
Together, the findings reveal a link between mitochondrial architecture, metabolism, and early fibrotic remodeling, highlighting how mitochondrial defects may contribute to tissue-specific disease. The cell model used also provides a platform to investigate these mechanisms further and identify potential metabolic or molecular vulnerabilities for future therapeutic strategies.
Reference material: Mitochondrion
Published in journal: Cell Death & Disease
Authors: Alexander Becker, Thomas O. Eichmann, Viacheslav Vasiliev, Kira an Mey, Patrick Petzsch, Andrea Rossi, Felix Distelmaier, and Ruchika Anand
Source/Credit: Heinrich Heine University Düsseldorf | Anne Wansing
Edited by: Scientific Frontline
Reference Number: bchm100126_01
